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Abstract: Several alkylating agents, e.g. alkyl halides and dimethyl sulfate, were employed in 
aprotic solvents under a variety of conditions for alkylation of mono and disubstituted 1H- or 
3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-diones, which were prepared by cyclization of 
the appropriate 5,6-diaminouracils with nitrous acid. The alkylation on the triazole ring in the 
presence of anhydrous potassium carbonate took place simultaneously at the 1- and 2-positions 
with the priority at the 2-position. The similar alkylation on the pyrimidine ring with an 
equivalent alkylating reagent took place only at the 4-position. The alkylation of the 
3,6-disubstituted derivatives at room temperature led to the 5-O-alkylation accompanied with the 
4-N-alkylation, but at high temperature only the 4-N-alkylation took place. The 
3,4,6-trisubstituted derivatives underwent transformation with excess alkylating agents at high 
temperature leading to the formation of 1,4,6-trisubstituted derivatives with elimination of the 
3-substituent. 
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Fused pyrimidines, e.g. naturally occurring purines, xanthines (I) and their analogues, possess 
wide biological activities such as antiviral1 and antitumor activities1c,d, 2 as well as xanthine 
oxidase inhibitory activities.3 In the past few decades, tremendous efforts have been directed to 
the search of potential anticancer and antiviral drugs without adverse effects, but very effective 
and less toxic one has not been found yet. Analogues of naturally occurring purine bases are 
valuable tools in defining chemical interactions involved in a specific biological response. 
Structural alternations of xanthine have resulted in several potent antagonists in biological 
systems,4 e.g. caffeine and theophylline exhibit a variety of pharmacological actions4f including 
antiasthmatic, diuretic, respiratory stimulant, central stimulant, cardiac stimulant, and analgesic 
adjuvant activities. Adenosine has different roles in modulating the function of the 
cardiovascular, endocrine, and nervous systems.5 A variety of analogues of xanthine with 
different substituents at the different positions have been assessed for potency and selectivity as 
antagonists at adenosine receptors.4 Hence, the alkylation of xanthine has been studied 
intensively,4b, 6 but the chemistry of 8-azaxanthine (II) has remained largely unexplored area in 
spite of their biological significance.7 The limited but encouraging success of clinical treatment8 
of neoplastic diseases in man or other animals by certain purine derivatives and related 
compounds has prompted us to synthesize and study the biological activity of purine derivatives 
and their analogues. Therefore, a program on synthesis of fused pyrimidine derivatives for 
biological evaluation has been in progress in our laboratory. The synthesis of 7H- and 
9H-[1,2,4]-triazolo[3,4-i]purines,9a, b 
7H-pyrazolo[4,3-e]-1,2,4-triazolo[4,3-c]pyrimidin-5(6H)-ones9c, d with potential xanthine oxidase 
inhibitory activities, 7-azapteridine antibiotics with potent anti-viral9e and anti-tumor activities9f 
as well as deazaflavin9g, h with redox system has been reported. In connection with this program, 
we communicated in a recent preliminary communication9i the reliable synthesis of substituted 
1H-, 2H- and 3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-diones (III) and the 
transformation of the 3-alkyl derivatives into 1-alkyl isomers, and the first study of their 
regioselective O- (IV) and N-alkylation (III). Herein we report full details of the synthesis of 
substituted 1H-, 2H- and 3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-diones (III) as well as 
comprehensive study of their regioselective alkylation and transformation in comparison with 
xanthine in view of evaluating the positional basis biological activity. 
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 The desired 1H- and 3H-[1,2,3]triazolo[4,5-d]pyrimi-dine-5,7(4H,6H)-diones (8-azaxanthines) 
2a-z were synthesized according to the previously outlined procedure.10, 11 Namely, 
6-chlorouracils12 were converted to the requisite 6-aminouracils by heating with appropriate 
amines, which on subsequent treatment with nitrous acid gave the corresponding 
6-amino-5-nitrosouracils. The reduction for nitroso group into amino group was carried out with 
sodium dithionite in dilute alkali solution,13 but the reduction of some hydrophobic nitroso 
compounds, e.g. 6-n-heptyl and 6-n-octylamino derivatives in aqueous medium, did not proceed 
smoothly enough. In completing the reduction within the shorter time, an addition of methanol 
was necessary. The final cyclization of the appropriate 5,6-diaminouracils 1a-z leading to the 
formation of substituted 1H- and 3H-[1,2,3]triazolo[4,5-d]-pyrimidine-5,7(4H,6H)-diones 2a-z 
was accomplished by treating with nitrous acid at room temperature in good yield (Scheme 1). 
The compound 2z was also prepared by one path reaction from 6-chloro-1,3-dimethyluracil 3,12c 
i.e. heating compound 3 with sodium azide in the presence of potassium carbonate in 
N,N-dimethylform-amide afforded the compound 2z in 67% yield via the formation of 
6-azido-1,3-dimethyluracil.12c 
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Scheme 1 
When 3-methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione 2a was treated with an 
equivalent methyl iodide in the presence of anhydrous potassium carbonate in dry 
N,N-dimethylformamide at boiling temperature afforded only the 3,4-dimethyl derivative 4a in 
62% yield (Scheme 2). Similarly, benzylation of 2a with an equivalent benzyl bromide under 
same conditions gave the 4-benzyl-3-methyl derivative 4b in 44% yield. Thus, the alkylation on 
the pyrimidine ring for the [1,2,3]triazolo[4,5-d]pyrimidine system took place not at the 
6-position but at the 4-position in spite of steric repulsion of the substituents at the 3-position and 
the 4-position. In the 1H NMR (DMSO-d6) spectrum, the singlet signal at δ 3.60 of 4a, assigned 
to methyl protons at the 4-position, was closer to other 4-N-methylated derivatives (δ 3.33–3.45) 
than 6-N-methylated derivatives (δ 3.18–3.38), and the mp 254–255 °C was also identical with 
reported mp 256 °C.10 It is noteworthy that the value ( δ 3.60) shifts from the usual value (δ 3.45 
for methyl at the 4-position of 10) to 1.5 ppm low magnetic field due to the peri-interaction of 
the substituents between 3- and 4-position. 
The chemical shift at δ 5.40 due to the 4-N-CH2Ph protons of 4b was also consistent with the 
value at δ 5.33 for 4-N-CH2Ph protons of another derivative 12c. The similar reaction of 2c with 
4 equivalent methyl iodide at 60 °C for overnight gave a mixture of 3-isopropyl-4-methyl 6 and 
3-isopropyl-4,6-dimethyl derivative 7 in 24% and 35% yield, respectively. Even in the presence 
of excess methylating agent in the reaction, the monomethylated derivative 6 was isolated 
together with 7. Therefore, it is obvious that the electrophilic substitution reaction on the 
pyrimidine ring happens more preferentially at the 4-position than at the 6-position. 
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Scheme 2 
The methylation of the 6-methyl derivative 2x with an equimolecular methyl iodide in 
N,N-dimethylformamide at boiling temperature resulted in the formation of two regioisomers of 
1,6-dimethyl 8 and 2,6-dimethyl derivative 9 in 23% and 42% yield, respectively (Scheme 3). 
The same methylation of 4-methyl derivative 2y also led to two regioisomers of 1,4-dimethyl 10 
and 2,4-dimethyl derivative 11 in 25% and 41% yield, respectively. Therefore, it is clear that the 
methylation on the [1,2,3]-triazolo[4,5-d]pyrimidine system with an equivalent alkylating 
reagent takes place not on the pyrimidine ring but only on the triazole ring. 1H NMR spectra of 
the methylated products provided sufficient evidence for methylation at the triazole ring. That is, 
the chemical shifts for all N-CH3 protons attached to the triazole ring usually appear at δ 4.0–4.4, 
whereas for N-CH3 protons attached to the pyrimidine ring these appear at δ 3.2–3.8. We 
observed the chemical shift in the former region (δ 4.0–4.3) for the newly appeared N-CH3 
protons attributable to a methyl group on the triazole ring. Some di-N-alkyl derivatives (e.g. 4a,b, 
8–11) were converted smoothly into tri-N-alkyl derivatives (5a,b, 12a–c, 13a,b) with appropriate 
alkyl halides in N,N-dimethyl-formamide at room temperature or at reflux temperature in good 
yields. 
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Scheme 3 
Senga et al. reported14 that heating 4-azido-1,3-dimethyl-uracil 14 with alkyl halide in the 
presence of potassium carbonate in N,N-dimethylformamide under reflux gave only 
1-alkyl-4,6-dimethyl-1H-[1,2,3]triazolo[4,5-d]-pyrimidine-5,7(4H,6H)-diones 12a,d. In the same 
reactions, we isolated the 2-alkyl derivatives 13a,c as the major product along with the 1-alkyl 
isomers 12a,d as shown in Scheme 4. We also carried out the direct alkylation of 2z with 
appropriate alkylating agents in dry N,N-dimethylformamide as well as in 1,4-dioxane at room 
temperature or boiling temperature to afford always a mixture of two regioisomers of 1- and 
2-alkyl derivatives. In all cases, the alkylation on the triazole ring got priority at the 2-position 
over at the 1-position. 
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Scheme 4 
As described in the above alkylation of 2x, 2y and 2z, it was clarified that the alkylation on the 
triazole ring always took place simultaneously at the 1- and 2-positions without at the 3-position. 
Thereupon, we prepared many 3-alkylated triazolopyrimidine derivatives 2a–z by the definitive 
method as can be seen in Scheme 1, whose physical and spectral data were quite different from 
the 1- and 2-alkylated products. The UV spectra for the alkylated compounds also contributed 
good evidence to assign the alkylated position, since the UV spectrum of the 1- or 2-alkylated 
each compound in ethanol showed only one maximum absorption band, while the 3-positional 
analog showed two maximum absorption bands. It is noteworthy that the most preferential 
alkylation was observed at the 2-position rather than at the 1-position, which might be due to the 
least electronic and inductive environment around the 2-position. For the differentiation of the 1- 
and 2-positional isomers, we prepared the 1,6-dimethylated derivative 8 according to the Scheme 
5, which on subsequent methylation yielded the 1,4,6-trimethylated derivative 12a as described 
in Scheme 3. That is, heating compound 2s with p-toluenesulfonic acid methyl ester at 130 °C 
gave the 
3-benzyl-1,6-dimethyl-5,7-dioxo-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-d]pyrimidinium 
tosylate 15.10 Commonly, removal of benzyl group from any compound is carried out by catalytic 
reduction, which is somehow complex method. We developed a simple and convenient method 
for removal of the benzyl group from the benzyl-triazolopyrimidinium tosylate system. Namely, 
we used sodium in liquid ammonia for the removal of benzyl group of 15 to produce the 
compound 8 in highly pure state and good yield. The 1H NMR spectra also provided evidence for 
discrimination of the 1- and 2-positional isomers exhibiting chemical shift for 1-methyl or 
1-methylene protons in the little more down field than that of 2-methyl or 2-methylene protons. 
For example, the chemical shift assigned to the 1-methyl protons of compound 12a appeared at 
δ 4.37, whereas for the 2-methyl protons of 13a it appeared at δ 4.28. The UV spectra also 
demonstrated the difference between the 1- and 2-positional isomers. That is, a maximum 
absorption band for the 1-positional isomers 8, 10, 12a–d appeared at longer wavelength 
(276–280 nm) than that for the 2-positinal isomers 9, 11, 13a–c (273–277 nm). Considering the 
above spectral analysis, we can allege that Senga et al.14 mistook to assign the proper position for 
alkylation. We found the melting points 220–222 °C (lit.,10 223–224 °C) for 1,4,6-trimethyl 12a, 
38–39 °C for 4,6-dimethyl-1-propyl 12d, 195–197 °C (lit.,10 197 °C) for 2,4,6-trimethyl 13a and 
79–80 °C for 4,6-dimethyl-2-propyl 13c derivatives, whereas they reported mps 202–203 °C and 
78–79 °C for compounds 12a and 12d, respectively. Therefore, considering the melting points of 
the 1- and 2-positional isomers, it can be said that in fact they did not isolate the 1-positional 
isomers but isolated the 2-positional isomers. 
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Scheme 5 
A superior and novel regioselective alkylation on 
3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-diones was accomplished in a simple way, 
which led to the 5-O-alkylation along with 4-N-alkylation (Scheme 6). The 5-O-alkylation on 
xanthine and 8-azaxanthine has not been claimed by anyone so far. Thus treatment of 
3,6-disubstituted derivatives 2l, r–t with excess an appropriate alkyl halide or dimethyl sulfate in 
the presence of potassium carbonate in N,N-dimethylformamide at room temperature gave the 
corresponding mixture of the 4-N-alkylated 5a, c–f and 5-O-alkylated isomers 16a–e (i). The 
ratio of yields between these two regioisomers was highly affected by size of both the alkylating 
agents and the 3-substituents. The 5-O-alkylation took place in preference to the 4-N-alkylation 
due to the steric repulsion between the bulkyer alkylating agents and 3-substituents, and the 
opposite result was achieved in the less steric repulsion. For example, when 3,6-dimethyl 
derivative 2l was treated with methyl iodide at room temperature, the O-methylation (16a) of 2% 
took place with 77% N-methylation (5a), and the same methylation with dimethyl sulfate yielded 
the O-methylation and N-methylation in 8% (16a) and 68% (5a), respectively. The ethylation of 
6-methyl-3-phenyl derivative 2r with ethyl iodide also contributed the clarification of more 
steric effect giving the O-ethyl isomer 16b and N-ethyl isomer 5c in 37% and 26% yield, 
respectively. The effect of great steric repulsion in the propylation of 3-benzyl-6-methyl 
derivatives (2s), which afford a mixture of the O-propyl derivative (16d, 54% yield) along with 
N-propyl isomer (13c, 13% yield), was observed. In contrast to the room temperature, at heating 
temperature with an equivalent alkyl halide only the 4-N-alkylation happened, e.g. compounds 2l 
and 2s gave the corresponding 5a and 5e in 59% and 60% yield, respectively (ii). However, in 
the case of the reaction with excess alkyl halide at heating under reflux, the transformation of 
alkyl group at the 3-position into the 1-position took place principally in single step. For example, 
heating compound 2l with four equivalent methyl iodide in N,N-dimethylformamide at boiling 
temperature afforded a mixture of compounds 5a and 12a in 22% and 58% yield, respectively 
(iii). The same reaction with more excess methyl iodide (ca. 10 eq, added dropwise) at boiling 
temperature gave only the compound 12a in 67% yield (iv). The formation of only the 
4-N-alkylated products (5a, c-f) with an equivalent alkylating agent at high temperature can be 
explained by the following fact. That is to say, the adequate energy is supplied to overcome the 
steric repulsion to afford only the comparatively more stable N-alkylated products. In order to 
confirm the 5-O-alkylation, we prepared compound 16a by the modified procedure15 outlined 
previously, i.e. heating 5-chloro derivative 17 with sodium methoxide in methanol afforded 
5-O-methyl derivative 16a (61%), whose physical and spectral data were quite identical in all 
respect with the first fraction isolated by column chromatography from a mixture of products 
obtained by the methylation of 2l at room temperature. The IR, 1H NMR, 13C NMR and UV 
spectra for the O-alkyl and N-alkyl isomers provided clear evidence for discrimination and 
identification of these products. Usually the IR spectra for 8-azaxanthines show two maximum 
absorption bands in the regions of 1660–1700 and 1715–1750 cm-1 due to the 5-CO and 7-CO 
groups, respectively. In the case of the O-alkylated derivatives, the absorption bands based on 
the 5-CO in the region of 1660–1700 cm-1 disappeared. This clearly indicated the disappearance 
of the 5-oxo group due to the formation of 5-O-alkyl derivatives. Moreover, the 1H NMR spectra 
displayed significant evidence showing the chemical shift for 5-O-CH protons (δ 4.04–4.61 for 
compounds 16a-e) in the more down field than that of 4-N-CH protons (δ 3.41–3.98 for 
compounds 5a, c–f) due to the inductive effect. It is also noteworthy that the chemical shift for 
the methyl/methylene group attached to the 3-position of 4-N-alkylated products appeared in the 
more down field as compared with the compound having no substituent at the 4-position, e.g. δ 
4.35 (3-CH3 for compound 5a) and δ 4.82–5.81 (3-CH2 for compound 5d–f), due to the steric 
repulsion with the 4-substituent. On the contrary, these values at the 3-position for the 
5-O-alkylated products appeared in the upper field of δ 4.14 (3-CH3 for compound 16a) and δ 
4.67–5.59 (3-CH2 for compound 16c–e), because the 5-O-alkyl group and 3-substitent are too far 
away to cause interaction. The UV spectra of the 3,4,6-trisubstituted derivatives 5a–f showed 
two maximum absorption bands at 240–243 and 256–257 nm, whereas the O-alkylated 
derivatives 16a–e exhibited only one band at 250–263 nm. The 13C NMR spectra of compounds 
5a, 12a, 13a and 16a were also measured. The chemical shift assigned to carbon of the methyl 
group attached to the oxygen appears much more down field (δ 56.63 for compound 16a) than 
that of any other methyl group (δ 28.21–42.98 for compounds 5a, 12a, 13a) attached to nitrogen 
due to the inductive effect. Thus, by comparison of several spectral data we distinguished and 
established the 5-O-alkylation along with the 4-N-alkylation for 8-azaxanthines. 
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Scheme 6 
We mentioned in the above paragraph that the methylation of 
3,6-dimethyl-3H-[1,2,3]triazolo[4,5-d]pyrimi-dine-5,7(4H,6H)-dione 2l with excess methyl 
iodide at heating temperature involved some transformation of the 3-methyl derivative (5a) into 
the 1-methyl isomer (12a) (iii and iv). Therefore, it should be noted that the alkylation 
demeanour of xanthine and 8-azaxanthine has some similarities. Usually the alkylation6 on the 
imidazole ring of xanthine takes place at the 7-postion, but not at the 9-position. Beside, in 1976 
we reported the first transformation6a of 9-substituted xanthines into the 7-substituted xanthines 
with excess of alkylating agents in aprotic solvent under heating via the formation of quaternary 
xanthinium derivatives alkylated at the 7-position and 9-position followed by elimination of the 
9-substituent. Herein we also successfully performed the similar transformation of 
3-alkyl-3H-[1,2,3]triazolo[4,5-d]pyrimi-dine-5,7(4H,6H)-diones (8-azaxanthines) into their 
1-alkyl derivatives as shown in Scheme 7. For example, heating 3,4,6-trimethyl derivative 5a 
with excess methyl iodide and propyl iodide in presence of potassium carbonate in 
N.N-dimethylformamide at boiling temperature resulted in the formation of the 1,4,6-trimethyl 
12a and 4,6-dimethyl-1-propyl derivative 12d in 53% and 61% yield, respectively, via the 
elimination of the 3-methyl group. Similarly, compounds 5f and 7 with excess methyl iodide 
afforded 12a in 49% and 47% yield with the removal of phenethyl and isopropyl group from the 
3-position, respectively. On heating of the 3,4,6-trialkyl derivative (5a) itself without alkyl 
halide in N,N-dimethylformamide, no corresponding transformation was observed. Therefore, a 
simple thermal transformation was excluded.  This necessity of extra alkylating agent suggests 
that the transformation is accompanied with alkylation at the 1-position of the 3-alkylated 
triazole moiety, formation of the quaternary salt, and elimination of alkyl group at the 3-position 
like xanthine to afford the corresponding 1-alkylated derivatives. The physical and spectral data 
of these transformed compounds were quite identical in all respects with the authentic samples 
prepared by another methods as shown in Scheme 4. 
N
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5a: R1 = Me
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12a: R2 = Me (53% from 5a, 49% 
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12d: R2 = Pr  (61% from 5a)  
Scheme 7 
Thus, this can be concluded that the direction of the electrophilic substitution toward 1H- and 
3H-[1,2,3]-triazolo[4,5-d]pyrimidine-5,7(4H,6H)-diones (8-aza-xanthines) suggests an important 
information on the electronic and inductive effects and steric repulsion of the alkyl groups at 
various positions. The triazole ring contains a single ‘tautomeric’ hydrogen atom and the 
alkylation in aprotic solvents suggests that the proton locates not as the 3-NH but as the 1-NH 
and 2-NH tautomers. Beside, the 4-NH proton of imide on the pyrimidone ring also remains as 
the lactam and lactim tautomers. Hence, the alkylation of the 3,6-disubstituted derivatives at 
room temperature led to the 5-O-alkylation accompanied with the 4-N-alkylation, but at high 
temperature only the 4-N-alkylation took place. The transformation of the 3-alkylated derivatives 
into the 1-alkylted isomers is facile like xanthine with excess alkyl halide under heating 
conditions. An order can be made for alkylation at different positions on the 
trizolopyrimi-dinediones according to the priority as follows: N2 > N1 > N4 > N6. Since 
xanthine and 8-azaxanthine have a great deal of coincidence in structure as well as affinity 
toward electrophile, so this can be expected that the positional alternation of 8-azaxanthine will 
result in potent biological activity. Therefore, the convenient synthesis for 8-azaxanthines is 
noteworthy to explore the biological activities in this area, and further analogues syntheses and 
biological activities are in progress. 
 
Mps were determined using a Yanagimoto micro-melting point hot stage apparatus and were 
uncorrected. IR spectra were obtained on a JASCO FT/IR-200 spectrophotometer in Nujol mulls. 
1H NMR spectra were recorded using a VXR 300 MHz spectrometer and chemical shift values 
were expressed in δ values (ppm) relative to TMS as an internal standard. Coupling constants are 
given in Hz. 13C NMR (75 MHz) spectra were also obtained using the same spectrometer. UV 
spectra were recorded in EtOH with a Beckman DU-68 spectrophotometer, and absorption 
values in italic refers to wave length at which shoulders or inflexions occur in the absorption. 
Microanalyses were measured using a Yanako CHN Corder MT-5-apparatus. Reaction progress 
was monitored by analytical thin-layer chromatography (TLC) on pre-coated glass plates (silica 
gel 60 F254 Plate-Merck) using the solvent systems of A (AcOEt–EtOH, 4:1) and B 
(n-hexane–EtOAc, 1:5 ) and products were visualized by UV light. Column chromatography was 
accomplished on Daisogel IR-60 (63/210 µm, Daiso Co.). All compounds were obtained as 
colorless crystals with a few pale yellow crystals. 
 
Preparation of 2a–z; General Procedure 
A mixture of the desired 5,6-diaminouracils (7.0 mmol) and 10% HCl (15 mL) was cooled to ca. 
5 °C in ice-water and a solution of sodium nitrite (12 mmol) in water (3 mL) was added to the 
mixture dropwise with stirring over 10 min. Then, the mixture was stirred at r.t. for 2–5 h. The 
solid deposited was collected by filtration, washed with water and dried to afford the 
corresponding 2a–z, which were recrystallised from appropriate solvents.  
 
3-Methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2a) 
Yield: 0.90 g (77%); mp 311–313 °C (H2O) (lit.10 312 °C); Rf = 0.21 (A). 
1H NMR (DMSO-d6): δ = 3.98 (s, 3 H, CH3), 11.11 (s, 1 H, 6-NH), 12.33 (br s, 1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 247 (3.98), 276 nm (3.83). 
 
3-Propyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2b) 
Yield: 0.98 g (72%); mp 281–283 °C (EtOH); Rf = 0.31 (A). 
IR (Nujol): 3210, 3090 (NH), 1735, 1700 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 0.93 (t, J = 7.2 Hz, 3 H, CH3), 1.84 (sext, J = 7.2 Hz, 2 H, N-CH2CH2), 
4.31 (t, J = 7.2 Hz, 2 H, N-CH2), 11.10 (s, 1 H, 6-NH), 12.31 (br s, 1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 249 (4.13), 281 nm (3.85). 
Anal. Calcd for C7H9N5O2: C, 43.08; H, 4.65; N, 35.88. Found: C, 42.94; H, 4.57; N, 36.03. 
 
3-Isopropyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2c) 
Yield: 1.01 g (74%); mp 306–308 °C (EtOH) (lit.16 303–306 °C); Rf = 0.35 (A). 
1H NMR (DMSO-d6): δ = 1.51 (d, J = 6.6 Hz, 6 H, 2 x CH3), 4.80 (sept, J = 6.6 Hz, 1 H, CH), 
11.16 (s, 1H, 6-NH), 12.25 (s, 1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 249 (4.23), 281 nm (3.84). 
 
3-Butyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2d) 
Yield: 1.01 g (69%); mp 272–273 °C (EtOH); Rf = 0.38 (A). 
IR (Nujol): 3210, 3050 (NH), 1720, 1700 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 0.90 (t, J = 7.2 Hz, 3 H, CH3), 1.24–1.32 (m, 2 H, N-CH2CH2CH2), 
1.73–1.78 (m, 2 H, N-CH2CH2), 4.34 (t, J = 7.2 Hz, 2 H, N-CH2), 11.19 (s, 1 H, 6-NH), 12.35 (s, 
1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 250 (4.03), 281 nm (3.78). 
Anal. Calcd for C8H11N5O2: C, 45.93; H, 5.30; N, 33.48. Found: C, 45.65; H, 5.19; N, 33.34. 
 
3-Isobutyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2e) 
Yield: 0.88 g (60%); mp 285–287 °C (EtOH); Rf = 0.37 (A). 
IR (Nujol): 3170, 3050 (NH), 1730, 1680 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 0.88 (d, J = 6.6 Hz, 6 H, 2 x CH3), 2.04–2.18 (m, 1 H, CH), 4.17 (d, J 
= 7.2 Hz, 2 H, CH2), 11.20 (s, 1 H, 6-NH), 12.38 (br s, 1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 250 (4.18), 282 nm (3.81). 
Anal. Calcd for C8H11N5O2: C, 45.93; H, 5.30; N, 33.48. Found: C, 45.69; H, 5.24; N, 33.20. 
 
3-Cyclopentyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2f) 
Yield: 1.02 g (66%); mp 299–301 °C (EtOH); Rf = 0.37 (A). 
IR (Nujol): 3160, 3080 (NH); 1730, 1680 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 1.63–1.70 (m, 2 H, cyclopentyl-H), 1.80–1.86 (m, 2 H, cyclopentyl-H), 
2.02–2.13 (m, 4 H, cyclopentyl-H), 4.88–4.98 (m, 1 H, N-CH), 11.18 (s, 1 H, 6-NH), 12.30 (br s, 
1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 249 (4.1), 280 nm (3.95). 
Anal. Calcd for C9H11N5O2: C, 48.86; H, 5.01; N, 31.66. Found: C, 48.96; H, 4.91; N, 31.74. 
 
3-Heptyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2g) 
Yield: 1.39 g (79%); mp 276–278 °C (EtOH); Rf = 0.44 (A). 
IR (Nujol): 3170, 3060 (NH); 1730, 1690 cm-1 (CO). 
1H NMR (CDCl3): δ = 0.88 (t, J = 7.2 Hz, 3 H, CH3), 1.26–1.32 (m, 8 H, CH2[CH2]4CH3), 
1.82–1.99 (m, 2 H, N-CH2CH2), 4.37 (t, J = 7.2 Hz, 2 H, N-CH2), 10.22 (s, 1 H, 6-NH), 12.43 (br 
s, 1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 249 (4.06), 279 nm (3.95). 
Anal. Calcd for C11H17N5O2: C, 52.58; H, 6.82; N, 27.87. Found: C, 52.47; H, 6.65; N, 27.57. 
 
3-Octyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2h) 
Yield: 1.50 g (81%); mp 273–275 °C (EtOH); Rf = 0.47 (A). 
IR (Nujol): 3210, 3050 (NH); 1725, 1700 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 0.85 (t, J = 7.2 Hz, 3 H, CH3), 1.15–1.38 (br s, 10 H, CH2[CH2]5CH3), 
1.72–1.82 (m, 2 H, N-CH2CH2), 4.33 (t, J = 7.2 Hz, 2 H, N-CH2), 11.17 (s, 1 H, 6-NH), 12.31 (s, 
1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 249 (4.12), 277 nm (3.86). 
Anal. Calcd for C12H19N5O2: C, 54.32; H, 7.22; N, 26.40. Found: C, 54.34; H, 7.21; N, 26.19. 
 
3-Phenethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2i) 
Yield: 1.66 g (92%); mp 300–302 °C (MeOH); Rf = 0.37 (A). 
IR (Nujol): 3170, 3070 (NH); 1735,1700 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 3.10 (t, J = 7.5 Hz, 2 H, Ph-CH2), 4.58 (t, J = 7.5 Hz, 2 H, N-CH2), 
7.17–7.30 (m, 5 H, Ph-H), 11.18 (s, 1 H, 6-NH), 12.31 (s, 1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 250 (4.18), 280 (4.03). 
Anal. Calcd for C12H11N5O2: C, 56.03; H, 4.31; N, 27.22. Found: C, 55.95; H, 4.36; N, 27.06. 
 
3-o-Tolyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2j) 
Yield: 1.48 g (87%); mp 281–283 °C (EtOH); Rf = 0.40 (A). 
IR (Nujol): 3170, 3050 (NH); 1730,1700 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 2.08 (s, 3 H, CH3), 7.41–7.54 (m, 4 H, Ar-H), 11.28 (s, 1 H, 6-NH), 
12.34 (s, 1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 255 (4.23), 281 nm (3.97). 
Anal. Calcd for C11H9N5O2: C, 54.32; H, 3.73; N, 28.79. Found: C, 54.50; H, 3.93; N, 28.49. 
 
3-m-Tolyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2k) 
Yield: 1.41 g (83%); mp 295–297 °C (EtOH); Rf = 0.27 (A). 
IR (Nujol): 3170, 3040 (NH); 1730,1700 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 2.42 (s, 3 H, CH3), 7.39–7.45 (m, 4 H, Ar-H), 11.32 (s, 1 H, 6-NH), 
12.38 (br s, 1 H, 4-NH). 
UV (EtOH): λmax (log ε) = 276 (4.18), 289 nm (4.18). 
Anal. Calcd for C11H9N5O2: C, 54.32; H, 3.73; N, 28.79. Found: C, 54.30; H, 3.89; N, 28.54. 
 
3,6-Dimethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2l) 
Yield: 0.96 g (76%); mp 298 °C (decomp., H2O) (lit.10 296 °C); Rf = 0.35 (A). 
1H NMR (DMSO-d6): δ = 3.20 (s, 3 H, 6-N-CH3), 3.99 (s, 3 H, 3-N-CH3), 12.69 (s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 252 (4.05), 278 nm (3.88). 
 
3-Isopropyl-6-methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2m) 
Yield: 0.91 g (62%); mp 269–271 °C ( EtOH); Rf = 0.61 (A). 
IR (Nujol): 3170 (NH); 1730, 1665 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 1.52 (d, J = 6.6 Hz, 6 H, CH3CHCH3), 3.19 (s, 3 H, N-CH3), 4.81 (sept, 
J = 6.6 Hz, 1 H, CH), 12.57 (s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 252 (4.10), 281 nm (3.90). 
Anal. Calcd for C8H11N5O2: C, 45.93; H, 5.30; N, 33.48. Found: C, 45.62; H, 5.20; N, 33.47. 
 
3-Isobutyl-6-methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2n) 
Yield: 1.11 g (71%); mp 241–243 °C ( EtOH); Rf = 0.64 (A). 
IR (Nujol): 3150 (NH); 1720, 1680 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 0.88 (d, J = 6.6 Hz, 6 H, CH3CHCH3), 2.07–2.16 (m, 1 H, CH), 3.19 (s, 
3 H, N-CH3), 4.20 (d, J = 7.2 Hz, 2 H, N-CH2), 12.63 (br s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 252 (4.25), 282 nm (3.91). 
Anal. Calcd for C9H13N5O2: C, 48.42; H, 5.87; N, 31.37. Found: C, 48.19; H, 5.77; N, 31.10. 
 
3-Cyclopentyl-6-methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2o) 
Yield: 1.30 g (79%); mp 272–275 °C ( EtOH); Rf = 0.62 (A). 
IR (Nujol): 3170 (NH); 1750, 1670 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 1.63–1.72 (m, 2 H, cyclopentyl-H), 1.78–1.88 (m, 2 H, cyclopentyl-H), 
1.97–2.15 (m, 4 H, cyclopentyl-H), 3.19 (s, 3 H, N-CH3), 4.86–4.98 (m, 1 H, N-CH), 12.61 (br s, 
1 H, NH). 
UV (EtOH): λmax (log ε) = 252 (4.14), 281 nm (3.95). 
Anal. Calcd for C10H13N5O2: C, 51.06; H, 5.57; N, 29.77. Found: C, 50.94; H, 5.57; N, 29.82. 
 
3-Cyclohexyl-6-methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2p) 
Yield: 1.24 g (71%); mp 294–296 °C ( EtOH); Rf = 0.67 (A). 
IR (Nujol): 3140 (NH); 1740, 1665 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 1.25–1.49 (m, 3 H, Cy-H), 1.69–1.91 (m, 5 H, Cy-H), 2.0–2.04 (m, 2 
H, Cy-H), 3.22 (s, 3 H, N-CH3), 4.40–4.49 (m, 1 H, N-CH), 12.59 (br s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 252 (4.06), 281 nm (3.78). 
Anal. Calcd for C11H15N5O2: C, 53.00; H, 6.07; N, 28.10. Found: C, 53.00; H, 6.05; N, 28.00. 
 
6-Methyl-3-octyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2q) 
Yield: 1.78 g (91%); mp 182–184 °C ( EtOAc); Rf = 0.68 (A). 
IR (Nujol): 3170 (NH); 1735, 1660 cm-1 (CO). 
1H NMR (CDCl3): δ = 0.86 (t, J = 6.6 Hz, 3 H, CH2CH3), 1.25–1.38 (m, 10 H, CH2[CH2]5CH3), 
1.92–2.01 (m, 2 H, N-CH2CH2), 3.45 (s, 3 H, N-CH3), 4.46 (t, J = 7.2 Hz, 2 H, N-CH2), 12.29 (s, 
1 H, NH). 
UV (EtOH): λmax (log ε) = 250 (4.08), 282 nm (3.92). 
Anal. Calcd for C13H21N5O2: C, 55.90; H, 7.58; N, 25.07. Found: C, 55.68; H, 7.36; N, 24.86. 
 
6-Methyl-3-phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2r) 
Yield: 1.58 g (93%); mp 295–297 °C ( EtOH); Rf = 0.51 (A). 
IR (Nujol): 3220 (NH); 1735, 1685 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 3.23 (s, 3 H, CH3), 7.61–7.65 (m, 5 H, Ph-H), 12.75 (br s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 279 (4.23), 289 nm (4.26). 
Anal. Calcd for C11H9N5O2: C, 54.32; H, 3.73; N, 28.79. Found: C, 54.09; H, 3.83; N, 29.11. 
 
3-Benzyl-6-methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2s) 
Yield: 1.44 g (80%); mp 238–240 °C (EtOH) (lit.10 240–241 °C); Rf = 0.60 (A). 
1H NMR (DMSO-d6): δ = 3.19 (s, 3 H, CH3), 5.63 (s, 2 H, CH2), 7.29–7.40 (m, 5 H, Ph-H), 
12.84 (s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 252 (4.05), 281 nm (3.99). 
 
6-Methyl-3-phenethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2t) 
Yield: 1.60 g (84%); mp 304–306 °C ( EtOH); Rf = 0.65 (A). 
IR (Nujol): 3140 (NH); 1730, 1660 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 3.11 (t, J = 7.5 Hz, 2 H, Ph-CH2), 3.18 (s, 3 H, CH3), 4.61 (t, J = 7.5 
Hz, 2 H, N-CH2), 7.18–7.27 (m, 5 H, Ph-H), 12.63 (s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 252 (4.08), 277 nm (3.99). 
Anal. Calcd for C13H13N5O2: C, 57.56; H, 4.83; N, 25.82. Found: C, 57.28; H, 4.88; N, 25.63. 
 
6-Methyl-3-o-tolyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2u) 
Yield: 1.37 g (76%); mp 254–256 °C ( EtOH); Rf = 0.66 (A). 
IR (Nujol): 3160 (NH); 1735, 1680 cm-1 (CO). 
1H NMR (CDCl3): δ = 2.16 (s, 3 H, Ar-CH3), 3.40 (s, 3 H, N-CH3), 7.32–7.52 (m, 4 H, Ar-H), 
12.28 (br s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 252 (4.07), 282 nm (3.66). 
Anal. Calcd for C12H11N5O2: C, 56.03; H, 4.31; N, 27.22. Found: C, 55.86; H, 4.38; N, 27.00. 
 
6-Methyl-3-m-tolyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2v) 
Yield: 1.40 g (78%); mp 245–247 °C ( EtOH); Rf = 0.61 (A). 
IR (Nujol): 3200 (NH); 1720, 1660 cm-1 (CO). 
1H NMR (CDCl3): δ = 2.47 (s, 3 H, Ar-CH3), 3.42 (s, 3 H, N-CH3), 7.34–7.49 (m, 4 H, Ar-H), 
12.28 (br s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 277 (4.15), 290 nm (4.19). 
Anal. Calcd for C12H11N5O2: C, 56.03; H, 4.31; N, 27.22. Found: C, 56.10; H, 4.42; N, 27.29. 
 
6-Methyl-3-p-tolyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2w) 
Yield: 1.50 g (83%); mp 282–284 °C ( EtOH); Rf = 0.60 (A). 
IR (Nujol): 3140 (NH); 1740, 1665 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 2.46 (s, 3 H, Ar-CH3), 3.25 (s, 3 H, N-CH3), 7.40 (d, J = 8.1 Hz, 2 H, 
Ar-mH), 7.49 (d, J = 8.1 Hz, 2 H, Ar-oH), 12.69 (br s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 277 (4.18), 290 nm (4.21). 
Anal. Calcd for C12H11N5O2: C, 56.03; H, 4.31; N, 27.22. Found: C, 56.05; H, 4.47; N, 27.10. 
 
6-Methyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2x) 
Yield: 0.92 g (79%); mp 259–261 °C (H2O) (lit.17 261 °C); Rf = 0.46 (A). 
1H NMR (DMSO-d6): δ = 3.24 (s, 3 H, CH3), 12.11 (br s, 1 H, 4-NH), 15.75 (br s, 1 H, 3-NH). 
UV (EtOH): λmax (log ε) = 264 nm (4.03). 
 
4-Methyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2y) 
Yield: 1.09 g (93%); mp 314–315 °C (H2O) (lit.17 316 °C); Rf = 0.40 (A). 
1H NMR (DMSO-d6): δ = 3.40 (s, 3 H, CH3), 11.37 (s, 1 H, 6-NH), 15.65 (br s, 1 H, 3-NH). 
UV (EtOH): λmax (log ε) = 265 nm (4.03). 
 
4,6-Dimethyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2z) 
Yield: 1.19 g (94%); mp 251–252 °C (EtOH) (lit.11 252–253 °C); Rf = 0.49 (A). 
1H NMR (DMSO-d6): δ = 3.25 (s, 3 H, 6-N-CH3), 3.44 (s, 3 H, 4-N-CH3), 15.90 (br s, 1 H, 
3-NH). 
UV (EtOH): λmax (log ε) = 268 nm (4.0). 
 
Preparation of 4,6-Dimethyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2z) by 
Another Method 
A mixture of 6-chloro-1,3-dimethyluracil (3, 1.0 g, 5.73 mmol), sodium azide (0.40 g, 6.15 
mmol) and anhyd K2CO3 (0.80 g, 5.79 mmol) in DMF (50 mL) was heated under reflux for 1.5 h. 
Then, the solvent was evaporated to dryness in vacuo and the residue was dissolved in water (15 
mL). The solution was acidified with dilute HCl and was kept in refrigerator for overnight. The 
solid deposited was collected by filtration followed by washing with water to give the compound 
2z (0.70 g, 67%), which was identical in all respects with the authentic sample prepared by the 
above general procedure. 
 
Methylation of 3-Methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2a) 
To a mixture of 2a (0.4 g, 2.39 mol) and anhyd K2CO3 (0.50 g, 3.62 mmol) in dry DMF (20 mL), 
MeI (0.34 g, 2.39 mmol) was added at r.t., and the mixture was heated under reflux for 2 h. After 
the solvent was evaporated to dryness in vacuo, the residue was dissolved in water (6 mL) and 
the resulting solution was acidified with dilute HCl. After keeping the solution in refrigerator for 
several hours, the solid deposited was collected by filtration, washed with a small quantity of 
cold water and dried to give the 3,4-dimethyl derivative (4a, 0.27 g, 62%); mp 254–255 °C 
(EtOAc) (lit.10 256 °C); Rf = 0.12 (B). 
1H NMR (DMSO-d6): δ = 3.60 (s, 3 H, 4-N-CH3), 4.27 (s, 3 H, 3-N-CH3), 11.51 (s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 238 (4.06), 255 nm (4.04). 
 Benzylation of 3-Methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2a) 
A mixture of 2a (0.3 g, 1.80 mmol), anhyd K2CO3 (0.37 g, 2.68 mmol) and benzyl bromide (0.31 
g, 1.81 mmol) in dry DMF (15 mL) was heated under reflux for 4 h. After the solvent was 
evaporated to dryness in vacuo, the residue was dissolved in water (6 mL) and the resulting 
solution was acidified with dilute HCl. The solid deposited was collected by filtration to give the 
4-benzyl-3-methyl derivative (4b, 0.2 g, 44%); mp 257–259 °C (EtOH); Rf = 0.27 (B). 
IR (Nujol): 3180 (NH); 1735, 1695 cm-1 (CO). 
1H NMR (DMSO-d6): δ = 3.95 (s, 3 H, N-CH3), 5.40 (s, 2 H, N-CH2), 7.21–7.36 (m, 5 H, Ph-H), 
11.65 (s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 237 (4.19), 254 nm (4.27). 
Anal. Calcd for C12H11N5O2: C, 56.03; H, 4.31; N, 27.22. Found: C, 56.18; H, 4.50; N, 27.24. 
 
Methylation of 3-Isopropyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2c) 
A mixture of 2c (0.5 g, 2.56 mmol), anhyd K2CO3 (1.0 g, 7.26 mmol) and MeI (1.45 g, 10.22 
mmol) in dry DMF (25 mL) was heated at 60 °C for overnight. After the solvent was evaporated 
to dryness in vacuo, the residue was dissolved in water (10 mL) and the resulting solution was 
acidified with dilute HCl. The products cropped were extracted with CH2Cl2 from the solution 
and the extract was dried over anhyd MgSO4. After evaporating the eluent in vacuo, two 
products were separated by column chromatography using n-hexane-EtOAc (5:3) as eluent to 
give the 4-methyl-3-isopropyl-3H- (6) and 4,6-dimethyl-3-isopropyl-3H- derivative (7). 
6: Yield: 0.13 g (24%); mp 234–236 °C (n-hexane-EtOAc); Rf = 0.21 (B).  
IR (Nujol): 3200 (NH); 1730, 1690 cm-1 (CO). 
1H NMR (CDCl3): δ = 1.75 (d, J = 6.6 Hz, 6 H, CH3CHCH3), 3.73 (s, 3 H, 4-N-CH3), 5.05 (sept, 
J = 6.6 Hz, 1 H, CH), 9.97 (br s, 1 H, 6-NH). 
UV (EtOH): λmax (log ε) = 236 (4.23), 256 nm (4.20). 
Anal. Calcd for C8H11N5O2: C, 45.93; H, 5.30; N, 33.48. Found: C, 45.80; H, 5.19; N, 33.27. 
 
7: Yield: 0.2 g (35%); mp 147–149 °C (n-hexane-EtOAc); Rf = 0.36 (B).  
IR (Nujol): 1720, 1680 cm-1 (CO). 
1H NMR (CDCl3): δ = 1.76 (d, J = 6.6 Hz, 6 H, CH3CHCH3), 3.45 (s, 3 H, 6-N-CH3), 3.79 (s, 3 
H, 4-N-CH3), 5.04 (sept, J = 6.6 Hz, 1 H, CH). 
UV (EtOH): λmax (log ε) = 240 (4.12), 256 nm (4.15). 
Anal. Calcd for C9H13N5O2: C, 48.42; H, 5.87; N, 31.37. Found: C, 48.08; H, 5.78; N, 31.27. 
 
Methylation of 6-Methyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2x) 
To a mixture of 2x (0.6 g, 3.59 mol) and anhyd K2CO3 (0.75 g, 5.43 mmol) in dry DMF (35 mL), 
MeI (0.51 g, 3.59 mmol) was added at r.t. and the mixture was heated under reflux for 2 h. The 
solvent was evaporated to dryness in vacuo, and the residue was dissolved in water (8 mL). The 
resulting solution was acidified with dilute HCl and was kept in refrigerator for several hours. 
The precipitate deposited was collected by filtration. The two products cropped were separated 
by column chromatography using n-hexane-EtOAc (3:1) as eluent to give the 1,6-dimethyl-1H- 
(8) and 2,6-dimethyl-2H- derivative (9). 
 
8: Yield: 0.15 g (23%); mp 274–276 °C (EtOAc) (lit.10 276–278 °C); Rf = 0.42 (B). 
1H NMR (DMSO-d6): δ = 3.20 (s, 3 H, 6-N-CH3), 4.25 (s, 3 H, 1-N-CH3), 12.33 (s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 276 nm (3.85). 
 
9: Yield: 0.27 g (42%); mp 314–315 °C (EtOAc) (lit.10 317–318 °C); Rf = 0.40 (B). 
1H NMR (DMSO-d6): δ = 3.20 (s, 3 H, 6-N-CH3), 4.23 (s, 3 H, 2-N-CH3), 12.17 (s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 273 nm (4.00). 
 
Methylation of 4-Methyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2y) 
The methylation of 2y was accomplished with an equiv MeI exactly following the above method 
to give the two regioisomers of 1,4-dimethyl-1H- (10) and 2,4-dimethyl-2H-derivatives (11). 
The solvent system used for separation of these isomers by column chromatography was 
n-hexane-EtOAc (5: 2). 
10: Yield: 25%; mp 295–297 °C (EtOAc) (lit.10 296–297 °C); Rf = 0.41 (B). 
1H NMR (DMSO-d6): δ = 3.45 (s, 3 H, 4-N-CH3), 4.26 (s, 3 H, 1-N-CH3), 11.59 (s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 279 nm (3.86). 
 
11: Yield: 41%; mp 268–270 °C (EtOAc) (lit.10 274 oC); Rf = 0.40 (B). 
1H NMR (DMSO-d6): δ = 3.33 (s, 3 H, 4-N-CH3), 4.25 (s, 3 H, 2-N-CH3), 11.47 (s, 1 H, NH). 
UV (EtOH): λmax (log ε) = 276 nm (4.00). 
 
Methylation of Compounds 4a,b and 8–11; General Procedure 
A mixture of the dialkylated derivatives (4a,b, 8–11, 1.1 mmol), anhyd K2CO3 (0.23 g, 1.66 
mmol) and MeI (0.47 g, 3.31 mmol) in dry DMF (15 mL) was stirred at r.t. or heating under 
reflux for 2–30 h. After the solvent was evaporated in vacuo, water was added (8 mL) to the 
residue and the resulting solution was acidified with dilute HCl. The product was extracted with 
CH2Cl2 from the solution and the extract was dried over anhyd MgSO4. The eluent was 
evaporated in vacuo and the resulting crude products were recrystallized from appropriate 
organic solvents to afford the corresponding trialkylated derivatives 5a, 5b, 12a, 13a, 12a and 
13a in 69%, 61%, 74%, 69%, 64% and 74% yield, respectively. 
 
3,4,6-Trimethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (5a) 
Mp 219–221 °C (EtOAc) (lit.18 222 oC); Rf = 0.17 (B). 
1H NMR (CDCl3): δ = 3.44 (s, 3 H, 6-N-CH3), 3.79 (s, 3 H, 4-N-CH3), 4.35 (s, 3 H, 3-N-CH3). 
13C NMR (CDCl3): δ = 28.32 (6-N-CH3), 30.95 (4-N-CH3), 36.54 (3-N-CH3), 124.83 (7a-C), 
140.31(3a-C), 150.38 (7-C), 156.96 (5-C). 
UV (EtOH): λmax (log ε) = 240 (4.06), 257 nm (4.08). 
 
4-Benzyl-3,6-dimethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (5b) 
Mp 179–181 °C (EtOAc) (lit.15 180–182 °C); Rf = 0.36 (B). 
1H NMR (DMSO-d6): δ = 3.38 (s, 3 H, 6-N-CH3), 4.05 (s, 3 H, 3-N-CH3), 5.50 (s, 2 H, N-CH2), 
7.34–7.46 (m, 5 H, Ph-H). 
UV (EtOH): λmax (log ε) = 243 (4.21), 257 nm (4.24). 
 
1,4,6-Trimethyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (12a) 
Mp 220–222 °C (n-hexane-EtOAc) (lit.10 223–224 °C); Rf = 0.49 (B). 
1H NMR (CDCl3): δ = 3.42 (s, 3 H, 6-N-CH3), 3.67 (s, 3 H, 4-N-CH3), 4.37 (s, 3 H, 1-N-CH3). 
13C NMR (CDCl3): δ = 28.34 (6-N-CH3), 30.28 (4-N-CH3), 37.17 (1-N-CH3), 113.14 (7a-C), 
150.29 (3a-C), 150.91 (7-C), 153.64 (5-C). 
UV (EtOH): λmax (log ε) = 280 nm (3.88). 
 
2,4,6-Trimethyl-2H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (13a) 
Mp 195–197 °C (n-hexane-EtOAc) (lit.10 197 °C); Rf = 0.47 (B). 
1H NMR (CDCl3): δ = 3.44 (s, 3 H, 6-N-CH3), 3.56 (s, 3 H, 4-N-CH3), 4.28 (s, 3 H, 2-N-CH3). 
13C NMR (CDCl3): δ = 28.45 (6-N-CH3), 30.90 (4-N-CH3), 42.98 (2-N-CH3), 125.10 (7a-C), 
149.61(3a-C), 151.20 (7-C), 156.14 (5-C). 
UV (EtOH): λmax (log ε) = 276 nm (4.00). 
 
Propylation of 1,6-Dimethyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (8) 
A mixture of 8 (0.2 g, 1.1 mmol), anhyd K2CO3 (0.23 g, 1.66 mmol) and propyl iodide (0.37 g, 
2.18 mmol) in dry DMF (15 mL) was heated under reflux for 4 h. After the solvent was 
evaporated in vacuo, water was added (8 mL) to the residue and the resulting solution was 
acidified with dilute HCl. Then, the product was extracted with CH2Cl2 from the solution and the 
extract was dried over anhyd MgSO4. Removal of the eluting solution in vacuo and purification 
by recrystallisation from n-hexane-EtOAc afforded the 1,6-dimethyl-4-propyl-1H- derivative 
(12b); yield: 0.16 g (65%); mp 73–74 °C (n-hexane-EtOAc); Rf = 0.68 (B). 
IR (Nujol): 1715, 1680 cm-1 (CO). 
1H NMR (CDCl3): δ = 1.0 (t, J = 7.5 Hz, 3 H, CH2CH3), 1.85 (sext, J = 7.5 Hz, 2 H, N-CH2CH2), 
3.43 (s, 3 H, 6-N-CH3), 4.15 (t, J = 7.5 Hz, 2 H, 4-N-CH2), 4.38 (s, 3 H, 1-N-CH3). 
UV (EtOH): λmax (log ε) = 280 nm (4.02). 
Anal. Calcd for C9H13N5O2: C, 48.42; H, 5.87; N, 31.37. Found: C, 48.27; H, 5.76; N, 31.34. 
 
Benzylation of Compounds 8 and 11; General Procedure 
Benzylation of 8 and 11 with two equiv benzyl bromide was carried out according to the above 
procedure to give 12c and 13b in 67 and 50%, respectively. 
 
4-Benzyl-1,6-dimethyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (12c) 
Yield: 67%; mp 134–136 °C (n-hexane-EtOAc); Rf = 0.58 (B). 
IR (Nujol): 1720, 1670 cm-1 (CO). 
1H NMR (CDCl3): δ = 3.41 (s, 3 H, 6-N-CH3), 4.36 (s, 3 H, 1-N-CH3), 5.33 (s, 2 H, N-CH2), 
7.28–7.36 (m, 3 H, Ph-m,pH), 7.57 (dd, Jo,p = 1.8 Hz, Jo,m = 7.8 Hz, 2 H, Ph-oH). 
UV (EtOH): λmax (log ε) = 280 nm (4.03). 
Anal. Calcd for C13H13N5O2: C, 57.56; H, 4.83; N, 25.82. Found: C, 57.42; H, 4.89; N, 25.65. 
 
6-Benzyl-2,4-dimethyl-2H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (13b) 
Yield: 50%; mp 118–120 °C (n-hexane-EtOAc); Rf = 0.63 (B). 
IR (Nujol): 1730, 1680 cm-1 (CO). 
1H NMR (CDCl3): δ = 3.53 (s, 3 H, 4-N-CH3), 4.28 (s, 3 H, 2-N-CH3), 5.22 (s, 2 H, N-CH2), 
7.25–7.30 (m, 3 H, Ph-m,pH), 7.51 (dd, Jo,p = 1.8 Hz, Jo,m = 7.8 Hz, 2 H, Ph-oH). 
UV (EtOH): λmax (log ε) = 277 nm (4.20). 
Anal. Calcd for C13H13N5O2: C, 57.56; H, 4.83; N, 25.82. Found: C, 57.94; H, 4.90; N, 25.85. 
 
Cyclization with Methylation of 6-Azido-1,3-dimethyl-1H-pyrimidine-2,4-dione (14) 
A mixture of 14 (0.5 g, 2.76 mmol), anhyd K2CO3 (0.57 g, 4.12 mmol) and MeI (1.18 g, 8.31 
mmol) in dry DMF (30 mL) was heated under reflux for 1.5 h. After the same work-up as 
mentioned in the method (i) gave 12a and 13a in 28% and 41% yield, respectively, which were 
quite identical in all respect with the methylated products of compound 2z. 
 
Cyclization with Propylation of 6-Azido-1,3-dimethyl-1H-pyrimidine-2,4-dione (14) 
A mixture of 14 (0.3 g, 1.66 mmol), anhyd K2CO3 (0.34 g, 2.46 mmol) and propyl iodide (0.84 g, 
4.94 mmol) in dry DMF (20 mL) was heated under reflux for 1.5 h. After the similar work-up 
and chromatography as mentioned in the method (iii), the compounds 12d and 13c were 
obtained in 19% and 49% yield, respectively, which were quite identical in all respect with the 
propylated products of compound 2z. 
 
12d: Yield: 0.07 g (19%); mp 38–39 °C (n-octane-EtOAc); Rf = 0.65 (B). 
IR (Nujol): 1715, 1670 cm-1 (CO). 
1H NMR (CDCl3): δ = 0.98 (t, J = 7.5 Hz, 3 H, CH2CH3), 2.02 (sext, J = 7.2 Hz, 2 H, 
N-CH2CH2), 3.43 (s, 3 H, 6-N-CH3), 3.69 (s, 3 H, 4-N-CH3), 4.67 (t, J = 7.2 Hz, 2 H, N-CH2). 
UV (EtOH): λmax (log ε) = 279 nm (4.03). 
Anal. Calcd for C9H13N5O2: C, 48.42; H, 5.87; N, 31.37. Found: C, 48.31; H, 5.77; N, 31.53. 
 
13c: Yield: 0.18 g (49%); mp 79–80 °C (n-octane-EtOAc); Rf = 0.60 (B). 
IR (Nujol): 1725, 1670 cm-1 (CO). 
1H NMR (CDCl3): δ = 0.98 (t, J = 7.5 Hz, 3 H, CH2CH3), 2.06 (sext, J = 7.2 Hz, 2 H, 
N-CH2CH2), 3.44 (s, 3 H, 6-N-CH3), 3.56 (s, 3 H, 4-N-CH3), 4.45(t, J = 6.9 Hz, 2 H, N-CH2). 
UV (EtOH): λmax (log ε) = 277 nm (4.17). 
Anal. Calcd for C9H13N5O2: C, 48.42; H, 5.87; N, 31.37. Found: C, 48.10; H, 5.65; N, 31.32. 
 
Alkylation of 4,6-Dimethyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (2z); 
General Procedure 
Methylation: 
(i) A mixture of 2z (0.5 g, 2.76 mmol), anhyd K2CO3 (0.57 g, 4.12 mmol) and MeI (1.18 g, 8.31 
mmol) in dry DMF (30 mL) was heated under reflux for 1.5 h. After the solvent was evaporated 
to dryness in vacuo, water (10 mL) was added to the residue and the resulting solution was kept 
in refrigerator for overnight. The solid deposited was collected by filtration followed by washing 
with water. The two isomers cropped were separated by column chromatography using 
n-hexane-EtOAc (7:2) as eluent to give the first and second fraction as 1,4,6-trimethyl-1H- (12a) 
and 2,4,6-trimethyl-2H- derivative (13a) in 17% and 55% yield, respectively.  
(ii) The above methylation of 2z with MeI at r.t. for 8 h gave 12a and 13a in 28% and 42% yield, 
respectively.  
(iii) A mixture of 2z (0.35 g, 1.93 mmol), K2CO3 (0.54 g, 3.91 mmol) and dimethyl sulfate (0.49 
g, 3.88 mmol) in dry DMF (20 mL) was heated under reflux 4 h. After the similar work-up and 
chromatography as mentioned in the method (i), the products 12a and 13a were obtained in 21% 
and 35% yield, respectively.  
(iv) The above methylation of 2z with dimethyl sulfate at r.t. 8 h gave 12a and 13a in 30% and 
44% yield, respectively.  
(v) A mixture of 2z (0.35 g, 1.93 mmol), anhyd K2CO3 (0.54 g, 3.91 mmol) and dimethyl sulfate 
(0.49 g, 3.88 mmol) in dry 1,4-dioxane (30 mL) was heated under reflux for 6 h. After the 
similar work-up and chromatography as mentioned in the method (i), the compounds 12a and 
13a were obtained in 22% and 36% yield, respectively.  
Propylation: 
A mixture of 2z (0.5 g, 2.76 mmol), anhyd K2CO3 (0.57 g, 4.12 mmol) and propyl iodide (1.41 g, 
8.31 mmol) in dry DMF (25 mL) was heated under reflux for 2 h. After the solvent was 
evaporated in vacuo, water (10 mL) was added to the residue and the resulting solution was 
acidified with dilute HCl. The products were extracted with CH2Cl2 from the solution and the 
extract was dried over anhyd MgSO4. Evaporation of the eluent in vacuo and separation of the 
products by column chromatography on silica gel using n-hexane-EtOAc (9:2) afforded the 
4,6-dimethyl-1-propyl-1H- (12d) and 4,6-dimethyl-2-propyl-2H-derivatives (13c) in 16% and 
62% yield, respectively. 
 
Debenzylation of 
3-Benzyl-1,6-dimethyl-5,7-dioxo-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-d]pyrimidinium 
tosylate (15) 
To a mixture of 1510 (1.2 g, 2.71 mmol) and liquid ammonia (20 mL) under cooling in dry ice 
with acetone, a few small pieces of sodium were added slowly with stirring until the permanent 
blue color solution existed. Then, a little ammonium chloride was added into the solution to 
remove the blue color. After excess ammonia of the solution was evaporated, water (8 mL) was 
added to the residue. The resulting solution was acidified with 10% HCl and was kept in 
refrigerator for several hours. The deposited solid was collected by filtration, washed with water 
and n-hexane to afford the product 8 (0.33 g, 67%). 
Regioselective Alkylation of 3,6-Disubstituted 
3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-diones  (2l, r–t) at Room Temperature; 
General Procedure 
A mixture of 3,6-disubstituted derivatives (2l, r–t, 2.9 mmol), anhyd K2CO3 (5.8 mmol) and an 
appropriate alkylating agent (8.7 mmol) in dry DMF (25 mL) was stirred at r.t. for 1–2 d. After 
the solvent was evaporated in vacuo, water (12 mL) was added to the residue and the resulting 
solution was acidified with dilute HCl. The products were extracted from the solution with 
CH2Cl2 and the extract was dried over anhyd MgSO4. Evaporation of the eluent in vacuo and 
separation of the residual products by column chromatography using n-hexane-EtOAc as eluting 
solvent always gave the corresponding a mixture of 4-N-alkylated and 5-O-alkylated isomers. 
(i) Methylation of 2l with MeI gave the 4-N-methyl (5a) and 5-O-methyl (16a) isomers in 77% 
and 2% yield, respectiely, whereas with dimethyl sulfate, the same isomers of 5a (68%) and 16a 
(8%) were obtained. (ii) Ethylation of 2r with ethyl iodide gave the 4-N-ethyl (5c) and the 
5-O-ethyl (16b) isomers in 26% and 37% yield, respectively. (iii) Ethylation of 2s with ethyl 
iodide gave the 4-N-ethyl (5d) and 5-O-ethyl (16c) isomers in 28% and 36% yield, respectively. 
(iv) Propylation of 2s with propyl iodide gave the 4-N-propyl (5e) and 5-O-propyl (16d) isomers 
in 13% and 54% yield, respectively. (v) Methylation of 2t with methyl iodide gave the 
4-N-methyl (5f) and 5-O-methyl (16e) isomers in 67% and 3% yield, respectively. 
 
5c: Mp 170–172 °C (n-octane-EtOAc); Rf = 0.63 (B). 
IR (Nujol): 1725, 1680 cm-1 (CO). 
1H NMR (CDCl3): δ = 0.99 (t, J = 7.2 Hz, 3 H, CH2CH3), 3.47 (s, 3 H, N-CH3), 3.74 (q, J = 6.9 
Hz, 2 H, 4-N-CH2), 7.51–7.55 (m, 2 H, Ph-mH), 7.61–7.69 (m, 3 H, Ph-o,pH). 
UV (EtOH): λmax (log ε) = 243 (4.18), 256 nm (4.21). 
Anal. Calcd for C13H13N5O2: C, 57.56; H, 4.83; N, 25.82. Found: C, 57.41; H, 4.85; N, 25.76. 
 
5d: Mp 162–164 °C (n-octane-EtOAc); Rf = 0.61 (B). 
IR (Nujol): 1720, 1670 cm-1 (CO). 
1H NMR (CDCl3): δ = 1.19 (t, J = 7.2 Hz, 3 H, CH2CH3), 3.42 (s, 3 H, N-CH3), 3.98 (q, J = 7.2 
Hz, 2 H, 4-N-CH2), 5.81 (s, 2 H, 3-N-CH2), 7.07-7.10 (m, 2 H, Ph-mH), 7.36-7.40 (m, 3 H, 
Ph-o,pH). 
UV (EtOH): λmax (log ε) = 242 (4.20), 256 nm (4.22). 
Anal. Calcd for C14H15N5O2: C, 58.94; H, 5.30; N, 24.55. Found: C, 58.91; H, 5.34; N, 24.16. 
 
5e: Mp 163–164 °C (n-octane-EtOAc); Rf = 0.66 (B). 
IR (Nujol): 1720, 1680 cm-1 (CO). 
1H NMR (CDCl3): δ = 0.93 (t, J = 7.8 Hz, 3 H, CH2CH3), 1.59 (sext, J = 7.8 Hz, 2 H, 
N-CH2CH2), 3.42 (s, 3 H, N-CH3), 3.84 (t, J = 8.1 Hz, 2 H, 4-N-CH2), 5.79 (s, 2 H, 3-N-CH2), 
7.05–7.08 (m, 2 H, Ph-mH), 7.37–7.42 (m, 3 H, Ph-o,pH). 
UV (EtOH): λmax (log ε) = 242 (4.21), 256 nm (4.23). 
Anal. Calcd for C15H17N5O2: C, 60.19; H, 5.72; N, 23.40. Found: C, 60.25; H, 5.73; N, 23.54. 
 
5f: Mp 185–187 °C (n-octane-EtOAc); Rf = 0.46 (B). 
IR (Nujol): 1725, 1670 cm-1 (CO). 
1H NMR (CDCl3): δ = 3.30 (t, J = 6.6 Hz, 2 H, Ph-CH2), 3.36 (s, 3 H, 6-N-CH3), 3.41 (s, 3 H, 
4-N-CH3), 4.82 (t, J = 6.9 Hz, 2 H, N-CH2), 7.0–7.03 (m, 2 H, Ph-mH), 7.26-7.30 (m, 3 H, 
Ph-o,pH). 
UV (EtOH): λmax (log ε) = 242 (4.12), 257 nm (4.17). 
Anal. Calcd for C14H15N5O2: C, 58.94; H, 5.30; N, 24.55. Found: C, 58.71; H, 5.40; N, 24.21. 
 
16a: Mp 175–177 °C (n-hexane-EtOAc) (lit.15 178–179 °C); Rf = 0.32 (B). 
1H NMR (CDCl3): δ = 3.50 (s, 3 H, 6-N-CH3), 4.09 (s, 3 H, 5-O-CH3), 4.14 (s, 3 H, 3-N-CH3). 
13C NMR (CDCl3): δ = 28.21 (6-N-CH3), 32.53 (3-N-CH3), 56.63 (5-O-CH3), 126.02 (7a-C), 
147.41(3a-C), 155.64 (7-C), 157.28 (5-C). 
UV (EtOH): λmax (log ε) = 250 nm (4.18). 
 
16b: Mp 164–166 °C (n-hexane-EtOAc); Rf = 0.69 (B). 
IR (Nujol): 1720 cm-1 (CO). 
1H NMR (CDCl3): δ = 1.51 (t, J = 7.2 Hz, 3 H, CH2CH3), 3.55 (s, 3 H, N-CH3), 4.61 (q, J = 7.2 
Hz, 2 H, O-CH2), 7.43–7.48 (m, 1 H, Ph-pH), 7.53–7.59 (m, 2 H, Ph-mH), 8.09–8.12 (m, 2 H, 
Ph-oH). 
UV (EtOH): λmax (log ε) = 263 nm (4.36). 
Anal. Calcd for C13H13N5O2: C, 57.56; H, 4.83; N, 25.82. Found: C, 57.38; H, 4.90; N, 25.61. 
 
16c: Mp 110–111 °C (n-hexane-EtOAc); Rf = 0.65 (B). 
IR (Nujol): 1720 cm-1 (CO). 
1H NMR (CDCl3): δ = 1.47 (t, J = 7.2 Hz, 3 H, CH2CH3), 3.48 (s, 3 H, N-CH3), 4.56 (q, J = 7.2 
Hz, 2 H, O-CH2), 5.59 (s, 2 H, N-CH2), 7.32-7.39 (m, 5 H, Ph-H). 
UV (EtOH): λmax (log ε) = 252 nm (4.26). 
Anal. Calcd for C14H15N5O2: C, 58.94; H, 5.30; N, 24.55. Found: C, 59.21; H, 5.43; N, 24.16. 
 
16d: oily amorphous; Rf = 0.71 (B). 
IR (Nujol): 1720 cm-1 (CO). 
1H NMR (CDCl3): δ = 1.07 (t, J = 7.5 Hz, 3 H, CH2CH3), 1.86 (sext, J = 6.6 Hz, 2 H, 
O-CH2CH2), 3.49 (s, 3 H, N-CH3), 4.45 (t, J = 6.6 Hz, 2 H, O-CH2), 5.59 (s, 2 H, N-CH2), 
7.32-7.39 (m, 5 H, Ph-H). 
UV (EtOH): λmax (log ε) = 252 nm (4.27). 
Anal. Calcd for C15H17N5O2: C, 60.19; H, 5.72; N, 23.40. Found: C, 59.91; H, 5.48; N, 23.15. 
 
16e: Mp 119–121 °C (n-hexane-EtOAc); Rf = 0.56 (B). 
IR (Nujol): 1710 cm-1 (CO). 
1H NMR (CDCl3): δ = 3.29 (t, J = 7.2 Hz, 2 H, Ph-CH2), 3.47 (s, 3 H, N-CH3), 4.04 (s, 3 H, 
O-CH3), 4.67 (t, J = 7.2 Hz, 2 H, N-CH2), 7.12–7.15 (m, 2 H, Ph-mH), 7.23–7.28 (m, 3 H, 
Ph-o,pH). 
UV (EtOH): λmax (log ε) = 252 nm (4.35). 
Anal. Calcd for C14H15N5O2: C, 58.94; H, 5.30; N, 24.55. Found: C, 58.57; H, 5.23; N, 24.39. 
 
Methylation of 2l under Heating 
With an equiv MeI: A mixture of 2l (0.3 g, 1.66 mmol), anhyd K2CO3 (0.34 g, 2.46 mmol) and 
MeI (0.24 g, 1.69 mmol) in dry DMF (15 mL) was heated under reflux for 2 h. After the similar 
work-up as noted above in general procedure and recrystallisation of the crude product from 
EtOAc afforded only the 4-N-methyl product 5a (0.19 g, 59%). 
With 4 equiv MeI: A mixture of 2l (0.5 g, 2.76 mmol), anhyd K2CO3 (0.57 g, 4.12 mmol) and 
MeI (1.57 g, 11.06 mmol) in dry DMF (25 mL) was heated under reflux for 2 h. After the similar 
work-up as noted above in general procedure and separation by column chromatography of the 
mixture of products using n-hexane-EtOAc (5:2 → 1:1) gave the pruducts 5a and 12a in 22% 
and 58% yield, respectively. 
With 10 equiv MeI: A mixture of 2l (0.4 g, 2.21 mmol), anhyd K2CO3 (0.60 g, 4.34 mmol) and 
MeI (0.95 g, 6.69 mmol) in dry DMF (25 mL) was heated under reflux for 5 h. In this reaction, 
another portion of MeI (0.57 g, 4.02 mmol) was added to the reaction mixture after every one 
hour. After the solvent was evaporated to dryness in vacuo, water (10 mL) was added to the 
residue and the resulting solution was acidified with dilute HCl. The product was extracted with 
CH2Cl2 from the solution. Then, the usual work-up and purification by column chromatography 
using n-hexane-EtOAc (2:1) as eluent gave only the product 12a (0.29 g, 67%). 
 
Propylation of 2s under Heating 
A mixture of 2s (0.43 g, 1.67 mmol), anhyd K2CO3 (0.34 g, 2.46 mmol) and propyl iodide (0.29 
g, 1.71 mmol) in dry DMF (15 mL) was heated under reflux for 2 h. After the similar work-up as 
mentioned in the methylation of 2l, only the 4-N-propyl product (5e) was obtained in 60% yield. 
 
Preparation of 3,6-Dimethyl-5-methoxy-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one (16a) 
via 17 
To a solution of sodium (0.03 g, 1.3 mmol) dissolved in absolute MeOH (25 mL), compound 
1715 (0.2 g, 1.0 mmol) was added and the mixture was heated under reflux for 30 min. After the 
solvent was evaporated to dryness in vacuo, and water (8 mL) was added to the residue and the 
resulting solution was acidified with dilute HCl. The product was extracted with CH2Cl2 from the 
solution and the extract was dried over anhyd MgSO4. Evaporation of the eluent in vacuo and 
purification of the residual product by crystallization from n-hexane-EtOAc gave 16a (0.12 g, 
61%). 
 
Transformation of 3,4,6-Trisubstituted Derivatives (5a,f, 7) into 1,4,6-Trisubstituted 
Derivatives (12a,d) 
(i) 3,4,6-Trimethyl derivative (5a) into 1,4,6-trimethyl derivative (12a): A mixture of 5a (0.2 g, 
1.03 mmol), anhyd K2CO3 (0.22 g, 1.59 mmol) and MeI (0.44 g, 3.1 mmol) in dry DMF (15 mL) 
was heated under reflux for 1 h. Then, another portion of MeI (0.29 g, 2.04 mmol) was added to 
the reaction mixture five times for after every one hour. Then, the solvent was evaporated to 
dryness in vacuo and water was added to the residue. After the resulting solution was acidified 
with dilute HCl, the product was extracted with CH2Cl2 from the solution, and the eluting 
solution was dried over anhyd MgSO4. After the usual work-up and purification by column 
chromatography using n-hexane-EtOAc (2:1) as eluent, the compound 12a was obtained in 53% 
yield. 
(ii) 4,6-Dimethyl-3-phenethyl derivative (5f) into 1,4,6-trimethyl derivative (12a): A mixture of 
5f (0.3 g, 1.05 mmol), anhyd K2CO3 (0.21 g, 1.52 mmol) and MeI (0.45 g, 3.17 mmol) in dry 
DMF (20 mL) was heated under reflux for 1 h. Then, another portion of MeI (0.3 g, 2.11 mmol) 
was added to the reaction mixture five times for very one hour. After evaporation of the solvent 
to dryness in vacuo, water was added to the residue and the resulting solution was acidified with 
dilute HCl. The product was extracted with CH2Cl2 from the solution. Then, the usual work-up 
and column chromatography for the product as noted above procedure gave 12a in 49% yield. 
(iii) 3-Isopropyl-4,6-dimethyl derivative (7) into 1,4,6-trimethyl derivative (12a): This 
transformation was carried out in the same manner as noted above procedure to give 12a (47%). 
(iv) 3,4,6-Trimethyl derivative (5a) into 4,6-dimethyl-1-propyl derivative (12d): A mixture of 5a 
(0.2 g, 1.03 mmol), anhyd K2CO3 (0.22 g, 1.59 mmol) and propyl iodide (0.35 g, 2.06 mmol) in 
dry DMF (15 mL) was heated under reflux for 4 h. Then, another portion of propyl iodide (0.25 
g, 1.47 mmol) was added to the reaction mixture three times for every four hours. After the 
solvent was evaporated to dryness in vacuo, water was added to the residue and the resulting 
solution was acidified with dilute HCl. The product was extracted with CH2Cl2 from the solution. 
Then, the usual work-up and column chromatography using n-hexane-EtOAc (5:2) as eluent 
afforded the compound 12d in 61% yield. 
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